78 related articles for article (PubMed ID: 20438394)
1. A unique combination of inhibitory and partially activating mutations in beta3 of a patient with variant-type Glanzmann thrombasthenia.
Nurden AT; Fernandes H; Fiore M; Nurden P; Vinciguerra C; Martins N; Sirvain-Trukniewicz P; Couloux A; Heilig R; Pillois X
Platelets; 2010; 21(6):498-500. PubMed ID: 20438394
[No Abstract] [Full Text] [Related]
2. Variant type Glanzmann thrombasthenia caused by homozygous p.724R>X mutation in beta3 integrin.
Bagoly Z; Fazakas F; Marosi A; Török O; Bereczky Z; Haramura G; Tóth J; Kappelmayer J; Muszbek L
Thromb Res; 2010 May; 125(5):427-31. PubMed ID: 20106508
[No Abstract] [Full Text] [Related]
3. A beta3 Asp217-->Val substitution in a patient with variant Glanzmann Thrombasthenia severely affects integrin alphaIIBbeta3 functions.
D'Andrea G; Bafunno V; Del Vecchio L; Amoriello A; Morabito P; Vecchione G; Grandone E; Margaglione M
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):657-62. PubMed ID: 18832906
[TBL] [Abstract][Full Text] [Related]
4. Reduced collagen-induced platelet aggregation in obligate heterozygotes of a Glanzmann thrombasthenia variant with a beta 3 mutation.
Nurden A; Jacquelin B; Tuleja E; Combrié R; Nurden P
Thromb Haemost; 2002 Aug; 88(2):364-5. PubMed ID: 12195716
[No Abstract] [Full Text] [Related]
5. Are bone defects in rare patients with Glanzmann's thrombasthenia associated with ITGB3 or ITGA2B mutations?
Nurden AT; Fiore M; Nurden P; Heilig R; Pillois X
Platelets; 2011; 22(7):547-51. PubMed ID: 21557682
[TBL] [Abstract][Full Text] [Related]
6. Two different beta3 cysteine substitutions alter alphaIIb beta3 maturation and result in Glanzmann thrombasthenia.
Milet-Marsal S; Breillat C; Peyruchaud O; Nurden P; Combrié R; Nurden A; Bourre F
Thromb Haemost; 2002 Jul; 88(1):104-10. PubMed ID: 12152649
[TBL] [Abstract][Full Text] [Related]
7. Mutations in GPIIIa molecule as a cause for Glanzmann thrombasthenia in Indian patients.
Nair S; Ghosh K; Shetty S; Mohanty D
J Thromb Haemost; 2005 Mar; 3(3):482-8. PubMed ID: 15748237
[TBL] [Abstract][Full Text] [Related]
8. Novel and recurrent mutations of ITGA2B and ITGB3 genes in Korean patients with Glanzmann thrombasthenia.
Park KJ; Chung HS; Lee KO; Park IA; Kim SH; Kim HJ
Pediatr Blood Cancer; 2012 Aug; 59(2):335-8. PubMed ID: 22190468
[TBL] [Abstract][Full Text] [Related]
9. ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia.
Nurden AT; Pillois X
Platelets; 2018 Jan; 29(1):98-101. PubMed ID: 29125375
[No Abstract] [Full Text] [Related]
10. AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.
Jallu V; Dusseaux M; Panzer S; Torchet MF; Hezard N; Goudemand J; de Brevern AG; Kaplan C
Hum Mutat; 2010 Mar; 31(3):237-46. PubMed ID: 20020534
[TBL] [Abstract][Full Text] [Related]
11. Two new beta3 integrin mutations in Indian patients with Glanzmann thrombasthenia: localization of mutations affecting cysteine residues in integrin beta3.
Nair S; Li J; Mitchell WB; Mohanty D; Coller BS; French DL
Thromb Haemost; 2002 Sep; 88(3):503-9. PubMed ID: 12353082
[TBL] [Abstract][Full Text] [Related]
12. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
Nurden AT; Pillois X; Nurden P
Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
[TBL] [Abstract][Full Text] [Related]
13. A novel Ser123Pro substitution in the MIDAS domain of integrin 3 associated with variant Glanzmann's thrombasthenia in an Indian patient.
Nair S; Ghosh K; Shetty S; Mohanty D
Haematologica; 2004 Dec; 89(12):1529-30. PubMed ID: 15590407
[TBL] [Abstract][Full Text] [Related]
14. [Novel frame-shift mutation of 540 A deletion in GP IIb gene from a patient with Glanzmann thrombasthenia].
Jian ZF; Tang FQ; Chen FP; Xie QZ; Wang GP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):165-8. PubMed ID: 18326913
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the cDNA Encoding alphaIIb and beta3 in normal horses and two horses with Glanzmann thrombasthenia.
Christopherson PW; Insalaco TA; van Santen VL; Livesey L; Bourne C; Boudreaux MK
Vet Pathol; 2006 Jan; 43(1):78-82. PubMed ID: 16407493
[TBL] [Abstract][Full Text] [Related]
16. Carrier detection in Glanzmann thrombasthenia: comparison of flow cytometry and Western blot with respect to DNA mutation.
Kannan M; Ahmad F; Yadav BK; Kumar P; Jain P; Kumar R; Saxena R
Am J Clin Pathol; 2008 Jul; 130(1):93-8. PubMed ID: 18550477
[TBL] [Abstract][Full Text] [Related]
17. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3.
Afrasiabi A; Gelain F; Artoni A; Mannucci PM
Platelets; 2008 Aug; 19(5):322-7. PubMed ID: 18791937
[TBL] [Abstract][Full Text] [Related]
18. No genetic abnormalities identified in α2IIb and β3: phenotype overcomes genotype in Glanzmann thrombasthenia.
Kannan M; Saxena R
Int J Lab Hematol; 2017 Apr; 39(2):e41-e44. PubMed ID: 27808476
[No Abstract] [Full Text] [Related]
19. Molecular genetic diagnosis of Tunisian Glanzmann thrombasthenia patients reveals a common nonsense mutation in the ITGA2B gene that seems to be specific for the studied population.
Aloui C; Chakroun T; Granados V; Jemni-Yacoub S; Fagan J; Khelif A; Kahloul N; Hammami S; Chkioua L; Barlier C; Cognasse F; Laradi S; Garraud O
Blood Coagul Fibrinolysis; 2018 Dec; 29(8):689-696. PubMed ID: 30325339
[TBL] [Abstract][Full Text] [Related]
20. A novel variant Glanzmann thrombasthenia due to co-inheritance of a loss- and a gain-of-function mutation of
Bury L; Zetterberg E; Leinøe EB; Falcinelli E; Marturano A; Manni G; Nurden AT; Gresele P
Haematologica; 2018 Jun; 103(6):e259-e263. PubMed ID: 29439184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
